Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1383145.RA_NulOWhC2NDqRoq-bjyExkwwLbRkUZXdjtCJ1qHho2U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1383145.RA_NulOWhC2NDqRoq-bjyExkwwLbRkUZXdjtCJ1qHho2U130_assertion type Assertion NP1383145.RA_NulOWhC2NDqRoq-bjyExkwwLbRkUZXdjtCJ1qHho2U130_head.
- NP1383145.RA_NulOWhC2NDqRoq-bjyExkwwLbRkUZXdjtCJ1qHho2U130_assertion description "[Because the epitope identified by PG-M3 is located in the aminoterminal portion of PML (AA 37 to 51), the antibody was suitable for recognizing APL cases characterized by breakpoint occurring at different sites of PML (bcr 1, bcr 2 and bcr 3).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1383145.RA_NulOWhC2NDqRoq-bjyExkwwLbRkUZXdjtCJ1qHho2U130_provenance.
- NP1383145.RA_NulOWhC2NDqRoq-bjyExkwwLbRkUZXdjtCJ1qHho2U130_assertion evidence source_evidence_literature NP1383145.RA_NulOWhC2NDqRoq-bjyExkwwLbRkUZXdjtCJ1qHho2U130_provenance.
- NP1383145.RA_NulOWhC2NDqRoq-bjyExkwwLbRkUZXdjtCJ1qHho2U130_assertion SIO_000772 9354674 NP1383145.RA_NulOWhC2NDqRoq-bjyExkwwLbRkUZXdjtCJ1qHho2U130_provenance.
- NP1383145.RA_NulOWhC2NDqRoq-bjyExkwwLbRkUZXdjtCJ1qHho2U130_assertion wasDerivedFrom befree-2016 NP1383145.RA_NulOWhC2NDqRoq-bjyExkwwLbRkUZXdjtCJ1qHho2U130_provenance.
- NP1383145.RA_NulOWhC2NDqRoq-bjyExkwwLbRkUZXdjtCJ1qHho2U130_assertion wasGeneratedBy ECO_0000203 NP1383145.RA_NulOWhC2NDqRoq-bjyExkwwLbRkUZXdjtCJ1qHho2U130_provenance.